IDO induces immune tolerance in the tumor microenvironment through the depletion of tryptophan, and its toxic catabolites subsequently inhibit T-cell proliferation and T-cell immune response (Hwu et al., 2000). This evidence concerns the gene IDO1 and neoplasm.